Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Molina Healthcare Announces Pricing of $750 Million of Senior Notes Due 2032 - Form 8-K

11/02/2021 | 07:40am EST
Molina Healthcare Announces Pricing of $750 Million of Senior Notes Due 2032

LONG BEACH, Calif.--(BUSINESS WIRE)--November 1, 2021--Molina Healthcare, Inc. (NYSE: MOH) (the "Company") today announced that it priced $750 million aggregate principal amount of its senior notes due 2032 (the "Notes") to be sold in a private offering to individuals reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain persons outside the United States in reliance on Regulation S under the Securities Act. The offering is expected to close on or about November 16, 2021 (such actual closing date, the "Settlement Date"), subject to the satisfaction of customary closing conditions.

The Notes will not be guaranteed by any of the Company's subsidiaries at the time of issuance. The Notes will bear interest at a rate of 3.875% per year. Interest will be payable semi-annually in arrears on May 15 and November 15 of each year, commencing May 15, 2022, and will accrue from the Settlement Date. The Notes will mature on May 15, 2032.

The Company estimates that after deducting fees and expenses payable by the Company, the net proceeds from the issuance and sale of the Notes will be approximately $741 million (the "Net Proceeds"). The Company intends to use approximately $725 million of the Net Proceeds to redeem the entire $700 million outstanding principal amount of its 5.375% senior notes due 2022. The Company intends to use the remaining Net Proceeds for general corporate purposes, which may include repayment of indebtedness, share repurchases, funding for acquisitions, capital expenditures, additions to working capital and capital contributions to the Company's health plan subsidiaries to meet statutory requirements in new or existing states.

The Notes have not been registered under the Securities Act or any state securities laws and may not be offered or sold within the United States or to, or for the benefit of, a U.S. person (as defined in Regulation S) except in transactions exempt from, or not subject to, the registration requirements of the Securities Act.

This press release shall not constitute an offer to sell or a solicitation of an offer to purchase the Notes and shall not constitute an offer, solicitation or sale in any state or jurisdiction where such offer, solicitation or sale is prohibited.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. Through its locally operated health plans, Molina Healthcare served approximately 4.8 million members as of September 30, 2021. For more information about Molina Healthcare, please visit molinahealthcare.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release contains "forward-looking statements," including statements related to the Company's offering of the Notes and intended use of net proceeds of the offering, which are subject to risks and uncertainties, including, without limitation, risks related to whether the Company will consummate the offering of the Notes on the expected terms, or at all, market and other general economic conditions, and whether the Company will be able to satisfy the conditions required to close any sale of the Notes. Additional information regarding the risk factors to which the Company is subject is provided in greater detail in its periodic reports and filings with the Securities and Exchange Commission, including its annual report on Form 10-K for the year ended December 31, 2020 and in its quarterly reports on Form 10-Q for the quarters ended March 31, 2021, June 30, 2021 and September 30, 2021. These reports can be accessed under the investor relations tab of the Company's website at www.molinahealthcare.com or on the SEC's website at www.sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or events projected or contemplated by its forward-looking statements will in fact occur, and it cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company's judgment as of the date hereof, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statements to conform the statement to actual results or changes in its expectations.


Investor Contact: Joseph Krocheski, Joseph.Krocheski@molinahealthcare.com, 562-951-8382
Media Contact: Caroline Zubieta, Caroline.Zubieta@molinahealthcare.com, 562-951-1588


Molina Healthcare Inc. published this content on 02 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 November 2021 12:39:11 UTC.

© Publicnow 2021
01/06Wells Fargo Adjusts Molina Healthcare Price Target to $304 From $281, Maintains Underwe..
01/05Molina Healthcare Announces Fourth Quarter and Year-End 2021 Earnings Release and Confe..
01/05Credit Suisse Raises Outperform-Rated Molina Healthcare's Price Target to $361 from $33..
01/04Molina Healthcare Acquires Cigna's Texas Medicaid Contracts
01/03Molina Healthcare Closes Acquisition of Cigna's Texas Medicaid Contracts
2021Goldman Sachs Reinstates Molina Healthcare at Buy With $335 Price Target
2021Deutsche Bank Resumes Coverage on Molina Healthcare at Hold With $194 Price Target
2021INSIDER SELL : Molina Healthcare
2021MOLINA HEALTHCARE : Announces Closing of Offering of $750 Million of 3.875% Senior Notes D..
More news
Analyst Recommendations on MOLINA HEALTHCARE, INC.
More recommendations
Financials (USD)
Sales 2021 27 440 M - -
Net income 2021 714 M - -
Net cash 2021 2 974 M - -
P/E ratio 2021 23,0x
Yield 2021 -
Capitalization 16 413 M 16 413 M -
EV / Sales 2021 0,49x
EV / Sales 2022 0,39x
Nbr of Employees 10 500
Free-Float 99,1%
Duration : Period :
Molina Healthcare, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MOLINA HEALTHCARE, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 15
Last Close Price 281,05 $
Average target price 336,71 $
Spread / Average Target 19,8%
EPS Revisions
Managers and Directors
Joseph M. Zubretsky President, Chief Executive Officer & Director
Mark L. Keim Chief Financial Officer
Dale B. Wolf Chairman
Jason Dees Senior Vice President-Marketplace
Ronna E. Romney Vice Chairman
Sector and Competitors
1st jan.Capi. (M$)
ANTHEM, INC.-2.33%108 807
HUMANA INC.-18.54%48 565